Stocksigma LogoStocksigma Logo

Sagility Limited Reports Strong Q2 FY27 Results and Chirok Health Acquisition

Sagility Limited posted a 22.5% YoY rise in Q2 FY27 consolidated revenue from operations to ₹20,321 million (12.2% constant currency growth)

Sagility Limited Reports Strong Q2 FY27 Results and Chirok Health Acquisition

Sagility Ltd · Outcome · 23 Oct 2026, 12:07 am

Sagility Limited Reports Strong Q2 FY27 Results and Chirok Health Acquisition Sagility Limited posted a 22.5% YoY rise in Q2 FY27 consolidated revenue from operations to ₹20,321 million (12.2% constant currency growth). Adjusted EBITDA rose 23.0% YoY to ₹5,353 million with margins at 26.3%, while consolidated PAT grew 13.3% YoY to ₹2,842.12 million. The company secured $40.2 million in ACV and approved an interim dividend of ₹0.15 per share (record date 30th Oct'26). Additionally, Sagility signed a definitive agreement on 21st Oct'26 to acquire US-based Chirok Health LLC for up to $32.35 million.

Original exchange filing (PDF)

More announcements from Sagility Ltd

All Sagility Ltd announcements